Kattan MW - Search Results

1

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Ankerst DP, Boeck A, Freedland SJ, Jones JS, Cronin AM, Roobol MJ, Hugosson J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ, Thompson IM. Ankerst DP, et al. Among authors: kattan mw. World J Urol. 2014 Feb;32(1):185-91. doi: 10.1007/s00345-012-0869-2. Epub 2012 Apr 22. World J Urol. 2014. PMID: 22527674 Free PMC article.

2

Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.

Goto Y, Ohori M, Arakawa A, Kattan MW, Wheeler TM, Scardino PT. Goto Y, et al. Among authors: kattan mw. J Urol. 1996 Sep;156(3):1059-63. J Urol. 1996. PMID: 8709307

3

The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer.

Rogers E, Gürpinar T, Dillioglugil O, Kattan MW, Goad JR, Scardino PT, Griffith DP. Rogers E, et al. Among authors: kattan mw. Br J Urol. 1996 Sep;78(3):419-25. doi: 10.1046/j.1464-410x.1996.00117.x. Br J Urol. 1996. PMID: 8881954

4

Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?

Soh S, Kattan MW, Berkman S, Wheeler TM, Scardino PT. Soh S, et al. Among authors: kattan mw. J Urol. 1997 Jun;157(6):2212-8. J Urol. 1997. PMID: 9146618

5

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.

Dillioglugil O, Leibman BD, Kattan MW, Seale-Hawkins C, Wheeler TM, Scardino PT. Dillioglugil O, et al. Among authors: kattan mw. Urology. 1997 Jul;50(1):93-9. doi: 10.1016/S0090-4295(97)00106-4. Urology. 1997. PMID: 9218025

6

Recall and attitudes in patients with prostate cancer.

Miles BJ, Giesler B, Kattan MW. Miles BJ, et al. Among authors: kattan mw. Urology. 1999 Jan;53(1):169-74. doi: 10.1016/s0090-4295(98)00456-7. Urology. 1999. PMID: 9886607

7

Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.

Adler HL, McCurdy MA, Kattan MW, Timme TL, Scardino PT, Thompson TC. Adler HL, et al. Among authors: kattan mw. J Urol. 1999 Jan;161(1):182-7. J Urol. 1999. PMID: 10037394

8

Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer.

Kubricht WS, Kattan MW, Sartor O, Eastham JA. Kubricht WS, et al. Among authors: kattan mw. Urology. 1999 Mar;53(3):553-6. doi: 10.1016/s0090-4295(98)00548-2. Urology. 1999. PMID: 10096383

9

Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.

Eastham JA, May R, Robertson JL, Sartor O, Kattan MW. Eastham JA, et al. Among authors: kattan mw. Urology. 1999 Oct;54(4):709-13. doi: 10.1016/s0090-4295(99)00213-7. Urology. 1999. PMID: 10510933

10

Race is not an independent predictor of positive surgical margins after radical prostatectomy.

Witte MN, Kattan MW, Albani J, Sharp DS, Eastham JA, Morton RA Jr. Witte MN, et al. Among authors: kattan mw. Urology. 1999 Nov;54(5):869-74. doi: 10.1016/s0090-4295(99)00273-3. Urology. 1999. PMID: 10565749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

703 results

Search Page

Filters